ReviewResearch and reports in urology2014

Short-term enzalutamide treatment for the potential remission of active surveillance or intermediate-risk prostate cancer: a case study, review, and the need for a clinical trial.

Mark A Moyad et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.